FLGC vs. TXMD, BNTC, RNXT, OCC, ONCT, SYBX, LSTA, CPIX, MEIP, and GDTC
Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include TherapeuticsMD (TXMD), Benitec Biopharma (BNTC), RenovoRx (RNXT), Optical Cable (OCC), Oncternal Therapeutics (ONCT), Synlogic (SYBX), Lisata Therapeutics (LSTA), Cumberland Pharmaceuticals (CPIX), MEI Pharma (MEIP), and CytoMed Therapeutics (GDTC).
TherapeuticsMD (NASDAQ:TXMD) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.
In the previous week, TherapeuticsMD and TherapeuticsMD both had 1 articles in the media. Flora Growth's average media sentiment score of 0.00 beat TherapeuticsMD's score of -0.50 indicating that TherapeuticsMD is being referred to more favorably in the media.
30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 1.2% of TherapeuticsMD shares are held by company insiders. Comparatively, 17.6% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
TherapeuticsMD has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 2, indicating that its stock price is 100% more volatile than the S&P 500.
TherapeuticsMD has a net margin of 0.00% compared to TherapeuticsMD's net margin of -75.33%. Flora Growth's return on equity of -25.54% beat TherapeuticsMD's return on equity.
TherapeuticsMD received 373 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 62.56% of users gave TherapeuticsMD an outperform vote while only 59.09% of users gave Flora Growth an outperform vote.
Flora Growth has a consensus target price of $7.00, suggesting a potential upside of 360.53%. Given TherapeuticsMD's stronger consensus rating and higher possible upside, analysts clearly believe Flora Growth is more favorable than TherapeuticsMD.
TherapeuticsMD has higher earnings, but lower revenue than Flora Growth.
Summary
TherapeuticsMD beats Flora Growth on 8 of the 15 factors compared between the two stocks.
Get Flora Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Flora Growth Competitors List
Related Companies and Tools
